Sequence analysis of the immunoglobulin heavy chain complementarity determining region (CDR)-III of B-lineage cells at various stages has provided important insights concerning B cell maturation and selection. Knowledge of human CDR-III sequences has been relatively limited compared with that of the murine system. We analyzed the CDR-III sequences of B cell precursor acute lymphoblastic leukemia (pre-B ALL) cells in 23 newly diagnosed and 10 relapsed patients, in order to elucidate the organization of CDR-III in B cell precursors. We found a very low frequency of somatic mutations in D and JH regions, preferential use of DLR, DXP, DHQ52, and DN elements, and of 3' side JH segments, and no predominant usage of D coding frames. Unusual joinings such as VH-D-D-JH and VH-JH were observed in three, and one sequences, respectively. We compared the CDR-III sequences derived from 10 patients between diagnosis and relapse. Two of them had three spots of mutated nucleotides at relapse, all of which were found in the N region near the D segments. Our data showed the possibility of somatic mutation at relapse, in addition to developmentally regulated rearrangement of the immunoglobulin gene at the stage of B cell precursors. JH were observed in three, and one sequences, respectively. We compared the CDR-III sequences derived from 10 patients between diagnosis and relapse. Two of them had three spots of mutated nucleotides at relapse, all of which were found in the N region near the D segments. Our data showed the possibility of somatic mutation at relapse, in addition to developmentally regulated rearrangement of the immunoglobulin gene at the stage of B cell precursors. (J. Clin. Invest. 1992. 89:739-746.)
Introduction
The immunoglobulin heavy chain (IgH)' variable region is encoded by three separate genes: variable (VH), diversity (D), and joining (JH) segments. During B lymphocyte differentiation, the IgH gene is assembled in two steps. D and JH segments are joined first, followed by VH to D-JH joining. During these joining steps, antibody diversity is generated by the following mech- 1 . Abbreviations used in this paper: CDR, complementarity determining region; D, diversity segment; dd-NTP-Fs, four dideoxynucleotide terminators; IgH, immunoglobulin heavy chain; JH, joining segment; P, palindromic; PCR, polymerase chain reaction; pre-B ALL, B cell precursor acute lymphoblastic leukemia; SSC, standard saline citrate; Tdt, terminal deoxynucleotidyl transferase; VH, variable segment. anisms: (a) somatic recombination of multiple VH, D, and JH segments; (b) variation of joining sites and addition of the N region nucleotides; and (c) somatic mutation (1) (2) (3) .
The assembled variable region ofthe Ig gene contains three hypervariable regions surrounded by framework regions that are relatively well conserved. These regions are called complementarity determining regions (CDR)-I, II, and III, and are thought to contact the antigenic epitope directly (1) (2) (3) (4) . CDR-I and II are encoded by a VH segment, and CDR-III is encoded by D elements, VH-D and D-JH junctional segments. As a result of these mechanisms, enormous diversity of CDR-III is created from a limited number of germline D segments (1) (2) (3) .
In murine system, recent studies have demonstrated several characteristics ofthe IgH gene at each stage ofB cell differentiation. First, the preferential use of the most 5' D segments, and the most JH-proximal D segments, is developed during initial D to JH joining in immature B cells (5) . Second, the CDR-III sequences from fetal and neonatal B-lineage cells preferentially use the JH-proximal VH genes (6) (7) (8) (9) . In contrast, adult B-lineage cells show random VH utilization (9) (10) (11) (12) (13) . Third, N region nucleotides are thought to be added by the enzyme terminal deoxynucleotidyl transferase (TdT) (14) (15) (16) (17) , and very few N region nucleotides are observed in most fetal and neonatal VH_ D-JH junctional sequences. The addition of N regions thus appears to be a developmentally regulated process in B cells (18) (19) (20) . Fourth, one particular reading frame of the D elements is preferentially used in productively rearranged VH-D-JH genes, and other reading frames are used at the stage of D-JH joining, although the joining border varies in each clone (21, 22) . It is suggested that the selection of reading frames is developmentally regulated at the stage of B cell ontogeny.
In the human system, DHQ52-J 1 joining was frequently observed in Epstein-Barr virus-transformed fetal B cell lines (23) .
Another study showed the biased use of JH segments (J3 > J4 > J5 > J1, J2) and the DHQ52 element in fetal liver (24) . Recently Yamada et al. reported that 3' side JH segments (J4, J5, and J6) were preferentially used, and all coding frames ofgermline D genes were used to generate CDR-IIIs in adult human peripheral B cells (25) . Until now, molecular studies of human B-lineage malignancies at various stages have provided many insights into B cell ontogeny. For example, follicular B cell lymphoma has extensive somatic mutations in the VH regions (26-28), although B cell precursor leukemia has few mutations (29) .
In this study, in order to elucidate the characteristics of CDR-III at the stage of B cell precursors, we have analyzed the CDR-III sequences from human B cell precursor acute lymphoblastic leukemia (pre-B ALL) cells using the polymerase chain reaction (PCR) amplification and a fluorescent chain-terminating dideoxy-nucleotide sequencing system. We demonstrate here the structure ofthe N region, the low frequency ofsomatic mutations in the D and JH regions, and the segments in the D and JH genes which are preferentially used. In addition, we compared the CDR-III sequences between initial diagnosis and relapse, and found the possibility of somatic mutation in pre-B ALL cells at relapse.
Methods
Leukemia cells. Bone marrow samples were taken from 23 patients (13 children and 10 adults) with pre-B ALL at the time of initial diagnosis or relapse, after informed consent was obtained. All bone marrow samples contained over 90% leukemia cells. The diagnosis of ALL in each patient was confirmed by standard morphological and immunophenotyping studies. All leukemia cells had an LI or L2 French-AmericanBritish (FAB) subtype, expressed HLA-DR, CDO0, and CD19 antigens, and lacked immunophenotypic evidence of both T (CD1, CD2, CD3, CD4, CD5, CD7, CD8) and mature B-cell lineage (CD20 and surface Ig). The expression ofcytoplasmic Mchain and TdT was examined by an immunofluorescence test. Karyotypic analysis revealed that five patients (patients S.B., S.I., F.K., S.M., and C.S.) had the Philadelphia chromosome (Ph'). In the 10 relapsed patients, the morphological, immunophenotypical, and karyotypical features of their leukemia cells were identical with those at initial diagnosis. These data are summarized in Table I .
Southern blot analysis. High molecular weight DNA was extracted from leukemia cells according to a previously published method (30 (35) (36) (37) . We also synthesized similar primers: Vcomm: 5'-GAGT- (40) . This sequencing system uses a special set of four dideoxynucleotide terminators (dd-NTP-Fs), each having a unique member of the succinyl fluorescein family attached. Single-stranded phage DNA, M13 MI-primer (Takara), and reaction buffer were heated at 90'C for 2 min and then transferred to a 370C water bath for 10 min to allow the primer to anneal. At this time, a single solution containing a mixture of each deoxynucleotide triphosphate (dCTP, dTTP, 7-deaza dATP, and 7-deaza dGTP), dd-NTP-Fs, DTT, and T-7 DNA polymerase (Takara) was prepared. An aliquot of this solution was added to the annealed mixture, and after a 5-min incubation, the unincorporated nucleotide, proteins, and reaction buffer were removed by ammonium acetate/ethanol precipitation. The DNA was washed with 70% ethanol and dried up, followed by resuspension in the loading solution. The mixture was then applied to the auto sequencer (Genesis 2000; DuPont Co.). The sequence data of each clone was determined if all the sequences from each recombinant plaque were identical.
Results
Southern blot analysis. All leukemia cells analyzed here demonstrated rearranged bands of the JH region in either HindIII, EcoRI, or the combination of HindIll and BamHI digests. In the 10 relapsed patients, the rearranged patterns were identical with those at initial diagnosis (summarized on Table I ).
Analysis of the CDR-III sequences from pre-B ALL. All genomic DNAs from the pre-B ALL cells were well amplified using the Vcomm and Jcomm primers. However, DNA from normal peripheral blood lymphocytes did not result in a significant band, and gave a faint smear after an additional 40-cycle PCR amplification (data not shown). In patient S.I., two amplified bands were observed that presumably corresponded to two rearranged IgH genes. We analyzed both bands and determined their CDR-III sequences.
The CDR-III sequences from the pre-B ALL cells are shown in Fig. 1 Fig. 2 . To clarify our data, previously described CDR-III sequences from pre-B ALL cells are also shown in Fig. 2 (29, 36, 37, 43) . The DLR family was most frequently used (our data: 41%, published data: 48%). The frequency ofthe DXP family (our data: 29%, published data: 29%) was a little lower than that of the DLR family. The D segment usage frequency gradient, i.e., DLR > DXP > DHQ52, DN > DK, DA > DM, is similar to the published data (29, 36, 37, 43) . (Fig. 1) .
Coding frame of D segment. Although all CDR-III sequences shown in Fig. 1 are not necessarily translated, nucleotide sequences corresponding to the D element are typed in triplets to identify the temporary coding frame. The frame sequence in VH segments were decided to start with TA(T/C) T(T/A)C TGT. In Table II the coding frames ofthe D segment are shown. All three coding frames were equally used. Ofinterest was the use of the first coding frame in the DLR family, which contained the stop codon, and was not used by the peripheral B cells.
JH segment. The JH segments of the sequenced clones were assigned to J -J6 according to published data (32). It could not be determined whether the JH segment from patient F.K. was assigned to J4 or J5, because several nucleotides were deleted at the 5' coding region of the JH segment. Somatic mutations of eight nucleotides (two nucleotides deleted, four nucleotides substituted, and two nucleotides inserted) were observed in 848 nucleotides encoded by the JH segments. This rate (8/848; 0.94%) is almost the same as that (4/412; 0.97%) in the nucleotides encoded by D segments. Furthermore, our sequences of J4, J5, and J6 had a discrepancy of one, two, and one nucleotides, respectively, compared with the published germ line sequences (32). However, since these have been reported as germ line polymorphisms (24), we did not include these discrepancies among the numbers described above.
The frequency of JH segment use was also examined (Fig.  3) . There was marked correlation between the 3 location and JH usage. This biased use was similar to previous reports in pre-B ALL (29, 36, 37, 43) , and appeared equally in the CDR-III of both children and adults. N region. We determined the 3 end of VH segment in each clone according to the published VH sequences (34) . Nucleotides which could not be assigned to any VH, D, nor JH segments were determined as N region. The N region nucleotides of 1 to 20 bases were observed at the VH-D junction in all clones. In three patients (T.Y., H.T., and S.M.), the N regions were surrounded by D elements as described above. At the D-JH junction, two clones (Y.M. and K.N.) lacked a N region, and other clones had 1 to 22 nucleotides. GC nucleotides were predominant (249/432; 58%) in the N region as previously described (14, 44) (Fig. 1) .
Although TdT is probably a responsible enzyme that mediates the addition ofthe N nucleotides (14) (15) (16) (17) , it was difficult to find a correlation between the expression of TdT in leukemia cells, and the length of the N nucleotides.
It has been proposed that palindromic (P) regions contribute tojunctional diversity (45) . The P region consists ofdinucleotides palindromic to the coding nucleotides adjacent to the signal heptamer. We found P nucleotides in 14 out of 24 clones, as shown in Fig. 1 . However, the contribution of P nucleotides to the N region formation of these clones may be difficult to assess, because there was no significant difference between the actual frequency ofthe inserted P nucleotides (24/ 96; 21%: number of the P region/number of VH-N, N-D, D-N, and N-JHjunctions that could potentially be inserted with P nucleotides.) and that of random nucleotide insertion (25%). TGOGfAA   TG0GAAA   T   TGOGAGA   TGOGAGAV   TGOGAGAG   TGOGGAG   TGOG4GAG   TGCGAG   TGOGAGAG   TG   TGCAA   TGCAA   gcttt The clones which could be examined both at initial diagnosis and relapse were counted as one clone.
Comparison ofCDR-III sequences between initial diagnosis and relapse. We compared the CDR-III sequences derived from 10 patients between initial diagnosis and relapse. Sequencing data were determined by examining several recombinant clones from each sample to exclude the possibilities of clonal heterogeneity and sequencing error. Although eight of them had completely matched sequences, the other two (K.M. and C.S.) differed by two or three nucleotides. To elucidate that these sequence differences were not due to Taq polymerase replication errors during early stages ofthe PCR amplification, we amplified genomic DNA from the initial and relapse specimens three times independently, and sequenced five recombinant clones derived from each amplified sample. Since each sequenced data (15 clones per one specimen) was completely identical, we could rule out the possibility of Taq polymerase replication errors. The mutated clones at relapse were thought to be the same as the original clones, because Southern blot analysis using JH probe showed similar patterns (Fig. 4) . Additionally, in patient K.M., a nucleotide insertion in the JH segment was observed at diagnosis, and also at relapse. In patient C.S., the D element mutation was observed in both clones. These nucleotide differences at relapse were therefore not due to clonal change but to somatic mutation. All these mutations occurred at the N region. In patient K.M., two nucleotides, GG in the VH-Dxp4 junction, and one nucleotide C adjacent to the 3' end ofthe Dxp4 element, had changed to CA and T at relapse, respectively. In patient C.S., two nucleotides GG downstream from the DHQ52 element had changed to TA at relapse (Fig. 1) .
Discussion
Knowledge of the DNA sequences of the human IgH variable region has so far been limited, in contrast to that ofthe murine system. Recently a rapid cloning and sequencing method for IgH CDR-III using PCR has been developed (25, (35) (36) (37) (38) 43) . Using this technique, we analyzed the CDR-III sequences from pre-B ALL cells.
Somatic mutation of the CDR-III sequences from pre-B ALL cells. As mentioned in Results, we found several characteristics of the CDR-III sequences from pre-B ALL cells. Somatic mutation ofD and JH segments was very rare (4/412 in D segments, 8/848 in JH segments). Furthermore, all of our sequences of J4, J5, and J6 had a discrepancy of one, two, and one nucleotides, respectively, compared with published germ line sequences (32). However, since these have been previously pointed out as germline polymorphisms (24), and the majority of sequenced human JH segments had the same nucleotide sequences as ours (24, 25, 29, 36 , 37, 43), we did not include these discrepancies among the numbers described above.
Somatic mutation appears to occur at specific stages of B cell development. Bird et al. reported that the rearranged VH genes from pre-B ALL showed no evidence ofmutation (29) . In Table II . Usage ofD coding Frame 1st 2nd 3rd
Total 8 (14) 7 (15) 11 (20) The coding frame of the D elements was temporary decided to start with TA(T/C) T(T/A)C TGT in the VH region. All three coding frames were equally used. The total number of our data and previously described data (29, 36, 37, 43) are listed in parentheses.
Immunoglobulin (52) . In fact, other investigators also reported the existence ofD-D joins which were observed more frequently in adult murine B cells (18, 20 (25) . In our findings and previously reported sequences derived from pre-B ALL cells (29, 36, 37, 43) , J4, J5, and J6 segments were equally used. It is not clear at the present time whether these discrepancies are due to the different utilization of B cells in each stage of ontogeny, or the selection resulting from malignant transformation.
Mutated CDR-III sequence at relapse. 2 out of 10 patients had mutated CDR-III sequences at relapse. All ofthese changes were observed within the N region near the D segments; in addition, the G nucleotide was most frequently substituted. Misincorporations due to the relative lack of fidelity of Taq polymerase might be the important problem with our approach. In order to rule out the possibility of Taq polymerase replication errors, we examined the genomic DNAs from these two patients three times independently, and confirmed the mutations. In the earlier studies, a cumulative error frequency was reported about 0.25% after 30 cycles of PCR (39) . However, recent studies using lower dNTP and Mg2" ion concentrations (200 uM each dNTP, and 1.5 mM MgCI2), which were the same as ours, have reported a significant increase in the fidelity of Taq polymerase. Now it is recognized that the cumulative error frequency is less than 6.6 X 10', and the average mutation rate is 5 X 10-6 errors per nucleotide incorporated per cycle, assuming 25 cycles of doubling (54, 55) .
Generally, somatic mutation has been thought to occur in mature B cells after antigenic stimulation. In the murine system, somatic mutation in antibody variable genes appeared early after primary immunization (56) . In a pre-B cell line, hypermutation at the IgH locus whose rate was determined to be 0.3-1 X 10' per cell generation, was reported (57) . On the other hand, in human systems it is not known from what stage human B cells mutate, although somatic mutations were frequently observed in follicular B cell lymphoma (26) (27) (28) 49) . Our data, however, suggests that a primary mutation might occur at specific sequences even at the stage of pre-B cell.
Recently Yamada et al. reported the usefulness of the tumor-specific CDR-III sequence to detect and monitor minimal residual disease at the level of l0', using the PCR amplification (43) . We also reported the detection of minimal residual disease at the level of 106 in a patient who had received an allogeneic bone marrow transplantation using two-step PCR amplification (38) . However the mutated CDR-III sequence cannot be detected, since these detection systems are based on the enormous diversity of CDR-III. The clinical usefulness of these systems, therefore, must be limited when the leukemia cells have mutated CDR-III sequences at relapse.
Structural analysis of CDR-III sequence is important to elucidate the B cell repertoire. As presented here, the sequential study of clinical lymphoid tumor samples can serve as a valuable model in B cell differentiation. Additionally, a rapid cloning and sequencing method of CDR-III could be applied to many clinical fields.
